Effects of bilobalide on gamma-aminobutyric acid levels and glutamic acid decarboxylase in mouse brain
- PMID: 10078989
- DOI: 10.1016/s0014-2999(98)00968-6
Effects of bilobalide on gamma-aminobutyric acid levels and glutamic acid decarboxylase in mouse brain
Abstract
We have previously demonstrated that bilobalide, a constituent of the Ginkgo biloba extract, possesses anticonvulsant activity, and suggested that the mechanism of its anticonvulsant action involves modulation of y-aminobutyric acid (GABA)-related neuronal transmission. This study examined the effects of bilobalide on the level of GABA and glutamate, the activity and the amount of glutamic acid decarboxylase (EC 4.1.1.15), and the function of GABA(A) receptors in the hippocampus, cerebral cortex and striatum of the mouse. GABA levels, glutamic acid decarboxylase activity, and the protein amount of 67 kDa glutamic acid decarboxylase in the hippocampus of mice treated with bilobalide (30 mg/kg, p.o., once a day for 4 days) were significantly higher than those in controls. However, there were no significant differences in glutamate levels or, the number and the dissociation constants of GABA(A) receptors in the hippocampus between control and bilobalide-treated mice. These results suggest that the anticonvulsant effect of bilobalide is due to elevation of GABA levels, possibly through potentiation of glutamic acid decarboxylase activity and enhancement of the protein amount of 67 kDa glutamic acid decarboxylase by bilobalide.
Similar articles
-
Bilobalide prevents reduction of gamma-aminobutyric acid levels and glutamic acid decarboxylase activity induced by 4-O-methylpyridoxine in mouse hippocampus.Life Sci. 2000 Jun 30;67(6):709-15. doi: 10.1016/s0024-3205(00)00657-3. Life Sci. 2000. PMID: 12659176
-
Effects of chronic administration of bilobalide on amino acid levels in mouse brain.Cell Mol Biol (Noisy-le-grand). 2002 Sep;48(6):681-4. Cell Mol Biol (Noisy-le-grand). 2002. PMID: 12396079
-
Effects of bilobalide on cerebral amino acid neurotransmission.Pharmacopsychiatry. 2003 Jun;36 Suppl 1:S84-8. doi: 10.1055/s-2003-40448. Pharmacopsychiatry. 2003. PMID: 13130394
-
Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer's disease.Pharmacopsychiatry. 2003 Jun;36 Suppl 1:S8-14. doi: 10.1055/s-2003-40454. Pharmacopsychiatry. 2003. PMID: 13130383 Review.
-
GABA and glutamate in the human brain.Neuroscientist. 2002 Dec;8(6):562-73. doi: 10.1177/1073858402238515. Neuroscientist. 2002. PMID: 12467378 Review.
Cited by
-
Herb-drug interactions: a literature review.Drugs. 2005;65(9):1239-82. doi: 10.2165/00003495-200565090-00005. Drugs. 2005. PMID: 15916450 Review.
-
Traditional Chinese medicine and Western psychopharmacology: building bridges.Phytother Res. 2013 Dec;27(12):1739-44. doi: 10.1002/ptr.4940. Epub 2013 Feb 17. Phytother Res. 2013. PMID: 23418138 Free PMC article. Review.
-
Pharmacological characterization of the neurotrophic sesquiterpene jiadifenolide reveals a non-convulsant signature and potential for progression in neurodegenerative disease studies.Biochem Pharmacol. 2018 Sep;155:61-70. doi: 10.1016/j.bcp.2018.06.022. Epub 2018 Jun 22. Biochem Pharmacol. 2018. PMID: 29940173 Free PMC article.
-
A GAD1 inhibitor suppresses osteosarcoma growth through the Wnt/β-catenin signaling pathway.Heliyon. 2024 May 17;10(10):e31444. doi: 10.1016/j.heliyon.2024.e31444. eCollection 2024 May 30. Heliyon. 2024. PMID: 38803976 Free PMC article.
-
Advantages of an antagonist: bicuculline and other GABA antagonists.Br J Pharmacol. 2013 May;169(2):328-36. doi: 10.1111/bph.12127. Br J Pharmacol. 2013. PMID: 23425285 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
